회사 개요
Wellgistics Health, Inc. is a specialized entity operating within the United States pharmaceutical distribution landscape, focusing on the wholesale and distribution of pharmaceutical products to both pharmaceutical manufacturers and independent retail pharmacies. The company's portfolio encompasses the supply of branded and generic pharmaceuticals, alongside over-the-counter healthcare and consumer products, positioning it firmly within the Healthcare sector as a Pharmaceutical Retailer. As of the latest available data, the company holds a market capitalization of $15.17M, supported by an annual revenue of $23.34M, while specific employee count details are not disclosed in the provided records. The valuation metrics indicate that Wellgistics Health operates as a micro-cap entity, suggesting a limited scale in the broader healthcare distribution market compared to major industry peers.
재무 건전성
The company reported a total revenue of $23.34M for the trailing twelve months, yet this revenue generation was accompanied by a net income loss of $-101,274,528 and an EBITDA of $-77,983,768, revealing a significant structural gap where operating expenses far exceed gross revenue. Despite the substantial net loss, the company generated positive free cash flow of $7.64M, which provides a degree of financial flexibility for operational continuity despite accounting losses. The gross margin stands at -27.5%, indicating that the cost of goods sold exceeds total revenue, a critical indicator of severe cost inefficiency or inventory valuation issues inherent to the business model. Furthermore, the operating margin is recorded at -766.0% and the profit margin at 0.0%, figures that collectively demonstrate a complete inability to cover operating expenses or generate profit from sales. On the liquidity front, the company holds only $42,571 in cash against a total debt obligation of $24.58M, resulting in a debt-to-equity ratio that is not calculable due to the negative equity position. This imbalance is further highlighted by a current ratio of 0.10, which signals a precarious short-term liquidity situation where current assets are insufficient to cover current liabilities. Additionally, the return on assets is -115.6% and the return on equity is not available, metrics that underscore the ineffective deployment of capital and the substantial erosion of shareholder value.
밸류에이션 평가
The trailing P/E ratio and forward P/E ratio are both listed as N/A, reflecting the company's status as a non-profitable entity where traditional earnings-based valuation multiples are inapplicable. The price-to-book ratio is -1.02, a negative figure that indicates the company's market value is below its book value and suggests the market does not assign a premium to its assets. Alternative valuation metrics such as the price-to-sales ratio of 0.65 and an EV/EBITDA of -0.48 provide insight into the company's pricing relative to sales volume, though the negative EV/EBITDA reinforces the fundamental challenges in generating economic profit. Regarding price volatility, the stock has traded between a 52-week high of $7.04 and a 52-week low of $0.10, illustrating an extreme range of movement typical of small-cap stocks with limited market capitalization. Without a specific beta value provided, the historical price action between these two extremes suggests high sensitivity to market sentiment and liquidity constraints rather than systematic market movements.
Growth & Income
The revenue growth year-over-year is -86.5%, while the earnings growth year-over-year is N/A, indicating a contraction in the core business operations without a clear trajectory toward profitability. Because the company reports a net loss, the concept of a dividend yield and payout ratio is N/A, meaning the company is not distributing cash to shareholders. Instead of paying dividends, the company is in a position where any generated free cash flow is necessary to cover operational deficits and debt obligations rather than being available for distribution to investors. The overall growth and income profile for Wellgistics Health, Inc. is characterized by significant revenue contraction and an absence of earnings or dividend income, presenting a challenging landscape for income-focused investors.